Stock listing

Madrigal Pharmaceuticals, Inc.

Selected listing: 0JXI · LSE · USD · GB

Madrigal Pharmaceuticals, Inc. (LSE:0JXI), Health Technology. Latest release Oct 6, 2026: Madrigal Announces Publication in the Journal of Hepatology…

0JXI:LSEUSDGBUpdated October 2, 2026

Ticker: LSE:0JXI
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LSE
Currency: USD

Latest news from Madrigal Pharmaceuticals, Inc.

Madrigal Announces Publication in the Journal of Hepatology Demonstrating Consistent Rezdiffra Efficacy Across Common MASH Genetic Risk Variants

October 6, 2026

Madrigal Pharmaceuticals to Participate in the 2026 Cantor Global Healthcare Conference

September 2, 2026

Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors

August 12, 2026

Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates

July 30, 2026

Madrigal Pharmaceuticals to Release Second-Quarter 2026 Financial Results and Host Webcast on July 30, 2026

July 16, 2026

All Madrigal Pharmaceuticals, Inc. news →

Events

Replays

Madrigal Pharmaceuticals, Inc. (MDGL) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 08:00 AM ET
Watch
Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2026 Earnings Call
Wed, May 06, 2026 · 08:00 AM ET
Watch
Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call
Thu, Feb 19, 2026 · 08:00 AM ET
Watch

Research Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. company profile

View the public company page for Madrigal Pharmaceuticals, Inc. on 6ix.

Madrigal Pharmaceuticals, Inc. news

Read company news and market updates connected to Madrigal Pharmaceuticals, Inc..

Madrigal Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Madrigal Pharmaceuticals, Inc..